...
CMECME Group Inc.
$272.59
Analysis updated: Jan 16, 2026

Investment Thesis

CME is a market laggard (RS 33/99, Top 67%) with weak fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.

Weak relative strength + ordinary growth = Pass

Key Takeaways

Earnings Momentum

+7%
Q4'24
$2.40
+11%
Q1'25
$2.62
+16%
Q2'25
$2.81
0%
Q3'25
$2.49
Earnings Growing

Price Structure

Broken Structure
Price
$272.59
50 DMA
$273.77
100 DMA
$269.77
150 DMA
$271.76
200 DMA
$271.80
Alignment Score: 1/4

CME Price Chart

Loading chart...

50 DMA150 DMA200 DMA
LEADERSHIP TEST FAILED

RS Rating 33/99 is in Bottom 33% of market. Minervini target: Top 20% (RS 80+)

Why Not BUY Yet?

RS Rating
33 (Top 67%)>80 (Top 20%)
EPS Growth
-0%>25% Qtr YoY
Pattern
No base formingVCP or constructive base
Breakout Status
-5.7% below entry ($289.00)Price above breakout entry

What Would Change Our Mind?

To turn bullish on CME, we need:

Twin Engines Dashboard

Technical Health

RS Rating
33/99
Top 67% (Need 80+)
Trend
Weak Uptrend
Above 200 DMA
RSI (14)
55
NEUTRAL
VCP Setup
COOL
Score: 3/9
Volume
1.7M
-10% vs avg
From Entry
-5.7%
$289.00

Fundamental Horsepower

EPS Qtr YoY
-0%
Declining
EPS 3Y CAGR
+10%
Annual Earnings
Revenue Qtr
N/A
NO DATA
F-Score
7/9
Piotroski Quality
ROE
13%
Return on Equity
EPS Rank
49/99
Percentile

Trade Plan

Struggling

Broke out 7 months ago at $289.00 — -6% below entry.

Breakout underperforming. Wait for price to reclaim entry or form a new base.

Breakout Date2025-05-30231 days ago
Entry Was$289.00Breakout price
Loss Since-6%From entry
Wait For$289.00Reclaim entry or new base

If/Then Playbook

IF: RS Rating improves to >80
THEN: Re-evaluate for WATCHLIST
IF: Price closes below 200 DMA
THEN: Remove from radar entirely
IF: EPS growth accelerates to >40% next quarter
THEN: Reassess as potential turnaround

Key Price Levels

Resistance

  • 50 DMA$273.77+0.4%
  • 52W High$290.79+6.7%
Current$272.59

Support

  • 200 DMA$271.80-0.3%
  • 20 DMA$271.46-0.4%
  • 52W Low$227.89-16.4%

Frequently Asked Questions

Is CME stock a buy now?

CME is a market laggard (RS 33/99, Top 67%) with weak fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.

What is the buy point for CME?

CME broke out at $289.00 7 month(s) ago but is now -6% below entry. Wait for new base pattern.

What is CME's RS Rating?

CME has an RS Rating of 33/99, meaning it's in the Top 67% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.

Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.